News - Page 199 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies

BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies

Post published:March 8, 2021
Post category:Press Release

Read more about the article Silo Wellness Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “SILO”

Silo Wellness Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “SILO”

Post published:March 5, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Atai Scoops $157m; Efficacy of Microdosing Under Scrutiny; Bright Minds Reduces Bing Eating in Rats

Psychedelic Bulletin: Atai Scoops $157m; Efficacy of Microdosing Under Scrutiny; Bright Minds Reduces Bing Eating in Rats

Post published:March 5, 2021
Post category:Psychedelic Bulletin

Read more about the article Red Light Holland Engages Former Canadian Special Operations Forces Officer, Glenn Cowan, Founder of One 9 Investments, to Advisory Board

Red Light Holland Engages Former Canadian Special Operations Forces Officer, Glenn Cowan, Founder of One 9 Investments, to Advisory Board

Post published:March 5, 2021
Post category:Press Release

Read more about the article MEC Signs RTO Definitive Agreement To Acquire Albert Labs, A European Psychedelic Drug Researcher & Developer

MEC Signs RTO Definitive Agreement To Acquire Albert Labs, A European Psychedelic Drug Researcher & Developer

Post published:March 5, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Application to List on OTCQB

Tryp Therapeutics Announces Application to List on OTCQB

Post published:March 4, 2021
Post category:Press Release

Read more about the article Silo Pharma, Inc. Enters into an Exclusive Option Agreement with the University of Maryland, Baltimore for patented Homing Peptides Targeting Rheumatoid Arthritis

Silo Pharma, Inc. Enters into an Exclusive Option Agreement with the University of Maryland, Baltimore for patented Homing Peptides Targeting Rheumatoid Arthritis

Post published:March 4, 2021
Post category:Press Release

Read more about the article MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™

MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™

Post published:March 4, 2021
Post category:Press Release

Read more about the article PsyBio Therapeutics Announces Retention of Market Maker

PsyBio Therapeutics Announces Retention of Market Maker

Post published:March 4, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

Post published:March 4, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.